Mitochondria boosting therapy rejuvenates immune system of mice
Longevity Technology - 11-Oct-2022If successful in humans it would improve the outcome of many age-related diseases
Tom Benson
Founder and CEO of Mitrix.Bio
Tom Benson is the CEO of Mitrix.Bio. Benson launched 2 companies and is the executive of Timepoint Capital.
He was also a manager at the Linac Coherent Light Source (LCLS) facility at Stanford Linear Accelerator National Laboratory, where he gained interest in the imaging of mitochondria via x-ray crystallography and Cryo-EM. This work led him to explore the recent fundamental changes in scientific understanding of cellular energetics and mitochondrial systems of the body.
Visit website: https://www.mitrix.bio/tom-benson.html
See also: 
Mitrix Bio
- California based start-up company
Details last updated 29-Jan-2021
Tom Benson is also referenced in the following:
Longevity Summit Dublin 2023
17-Aug-2023 to 20-Aug-2023
Club discount available - click here
Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers
Tom Benson News
Mitochondrial transplants show efficacy in achieving longevity in humans
Lifespan.io (LEAF) - 19-Jul-2022Mitochondrial transplant raise energetics of the body, so it can withstand longevity treatments
Mitlets improve immunity and treat many age-related diseases
Longevity Technology - 22-Oct-2021Experimental therapy to transfuse healthy mitochondria from multiple donors
Mitrix gains funding to transfuse young mitochondria
Longevity Technology - 28-Jan-2021Trials on mitochondrial transfusion might help tackle many ageing diseases
